Allogeneic Transplantation for Unfavorable-Risk Acute Myeloid Leukemia
1Moffitt Cancer Center, Tampa, FL.
Clinical Lymphoma, Myeloma & Leukemia
|August 23, 2015
Abstract:
Acute myeloid leukemia (AML) is a complex, heterogeneous disorder that can have devastating effects. Although control of AML can be attained with various induction regimens, long-term cure is much more difficult to maintain. This is understated in patients with unfavorable-risk AML, who are usually older and have prior myeloid and/or therapy-related disease and more challenges in curing this disease.


